Læknaneminn - 01.04.2021, Blaðsíða 44

42 Læknaneminn
26. Simelela PN. WHO global strategy to
eliminate cervical cancer as a public
health problem: An opportunity to make
it a disease of the past. Int J of Gynaecol
Obstet. 2021;152(1):1-3.
27. World Health Organization. Major
milestone reached as 100 countries have
introduced HPV vaccine into national
schedule 2019 [Sótt þann 14. mars 2021].
Aðgengilegt á: https://www.who.int/
news/item/31-10-2019-major-milestone-
reached-as-100-countries-have-
introduced-hpv-vaccine-into-national-
schedule.
28. Hall MT, Simms KT, Lew J-B, Smith MA,
Brotherton JML, Saville M, et al. The
projected timeframe until cervical cancer
elimination in Australia: a modelling study.
Lancet Public Health. 2019;4(1):e19-e27.
29. Bruni L, Diaz M, Barrionuevo-Rosas L,
Herrero R, Bray F, Bosch FX, et al. Global
estimates of human papillomavirus
vaccination coverage by region and
income level: a pooled analysis. Lancet
Glob Health. 2016;4(7):453-63.
30. NHS. HPV vaccine overview 2019
[Sótt þann 14. mars 2021]. Aðgengilegt
á: https://www.nhs.uk/conditions/
vaccinations/hpv-human-papillomavirus-
vaccine/.
31. Finnish Institute for Health and Welfare.
HPV, or human papillomavirus vaccine
2020 [Sótt þann 14. mars 2021].
Aðgengilegt á: https://thl.fi/en/web/
infectious-diseases-and-vaccinations/
vaccines-a-to-z/hpv-or-human-
papillomavirus-vaccine.
32. Folkehelseinstituttet. HPV-vaksine
(Humant papillomavirus) - veileder for
helsepersonell 2020 [Sótt þann 14. mars
2021]. Aðgengilegt á: https://www.fhi.
no/nettpub/vaksinasjonsveilederen-for-
helsepersonell/vaksiner-mot-de-enkelte-
sykdommene/hpv-vaksinasjon-humant-
papillomavir/.
33. Folkhälsomyndigheten. Vaccin mot
humant papillomvirus (HPV) 2020 [Sótt
þann 14. mars 2021]. Aðgengilegt á:
https://www.folkhalsomyndigheten.se/
smittskydd-beredskap/vaccinationer/
vacciner-a-o/humant-papillomvirus-hpv/.
34. Statens Serum Institut. Vaccination mod
Human Papilloma Virus (HPV) 2020
[Sótt þann 14. mars 2021]. Aðgengilegt
á: https://www.ssi.dk/vaccinationer/
boernevaccination/vaccination-mod-
livmoderhalskraeft.
35. Mikaelsdottir EK, Benediktsdottir KR,
Olafsdottir K, Arnadottir T, Ragnarsson
GB, Olafsson K, et al. HPV subtypes and
immunological parameters of cervical
cancer in Iceland during two time periods,
1958–1960 and 1995–1996. Gynecol
Oncol. 2003;89(1):22-30.
36. Embætti landlæknis. HPV-bólusetning
utan almenns skema á Íslandi 2019
[Sótt þann 14. mars 2021]. Aðgengilegt
á: https://www.landlaeknir.is/um-
embaettid/greinar/grein/item37697/
HPV-bolusetning-utan-almenns-skema-
a-Islandi.
37. World Health Organization. HPV gender
recommendation table. 2021.
38. Brisson M, Bénard É, Drolet M,
Bogaards JA, Baussano I, Vänskä S,
et al. Population-level impact, herd
immunity, and elimination after human
papillomavirus vaccination: a systematic
review and meta-analysis of predictions
from transmission-dynamic models.
Lancet Public Health. 2016;1(1):e8-e17.
39. Johnson LG, Madeleine MM, Newcomer
LM, Schwartz SM, Daling JR. Anal
cancer incidence and survival: The
Surveillance, Epidemiology, and End
Results experience, 1973–2000. Cancer.
2004;101(2):281-8.
40. Scholefield JH, Castle MT, Watson NFS.
Malignant transformation of high-grade
anal intraepithelial neoplasia. Br J Surg.
2005;92(9):1133-6.
41. Palefsky JM, Giuliano AR, Goldstone S,
Moreira ED, Aranda C, Jessen H, et al.
HPV Vaccine against Anal HPV Infection
and Anal Intraepithelial Neoplasia. N Engl
J Med. 2011;365(17):1576-85.
42. Giuliano AR, Palefsky JM, Goldstone S,
Moreira ED, Penny ME, Aranda C, et al.
Efficacy of Quadrivalent HPV Vaccine
against HPV Infection and Disease in
Males. N Engl J Med. 2011;364(5):401-11.
43. Chaturvedi AK, Graubard BI, Broutian
T, Pickard RKL, Tong Z-Y, Xiao W,
et al. Effect of Prophylactic Human
Papillomavirus (HPV) Vaccination on
Oral HPV Infections Among Young
Adults in the United States. J Clin Oncol.
2018;36(3):262-7.
44. Korostil IA AH, Guy RJ, Donovan B,
Law MG, Regan DG. Near elimination
of genital warts in Australia predicted
with extension of human papillomavirus
vaccination to males. Sex Transm Dis
2013;40(11):833-5.
45. Depuydt CE DG, Verstraete L, Vanden
Broeck D, Beert JFA, Salembier G, et
al. . Infectious human papillomavirus
virions in semen reduce clinical
pregnancy rates in women undergoing
intrauterine insemination. Fertil Steril.
2019;111(6):1135-44.
46. Ng SS, Hutubessy R, Chaiyakunapruk N.
Systematic review of cost-effectiveness
studies of human papillomavirus
(HPV) vaccination: 9-Valent vaccine,
gender-neutral and multiple age cohort
vaccination. Vaccine. 2018;36(19):2529-44.
47. Stanley M. HPV vaccination in boys
and men. Hum Vacc Immunother.
2014;10(7):2109-11.Surg. 2003;31(4):
197-201.
48. Green A. HPV vaccine to be
offered to boys in England. Lancet.
2018;392(10145):374.